Request PowerPoint
PowerPoint animations are preserved in the original file.
Slide index (76)
- Loading slide titles…
Loading presentation…
Slide text will appear here when the presentation loads.
Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.
Lecture topics
- The organizing principle: Architecture before label
- Nottingham grade measures differentiation
- “Usually” is not “always” for receptor groups
- Mucinous carcinoma: Tumor islands in mucin
- Invasive micropapillary carcinoma forms hollow balls
- Triple-negative carcinomas are histologically diverse
- Most invasive cancers present as a palpable or screened mass
- Primary reference and source limits
Slide index & full transcript (76 slides)
Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.
Slide 1 · Types of Invasive Breast Carcinoma
Histologic patterns, biologic associations, and diagnostic distinctions
Invasive carcinoma of no special type • Special histologic subtypes • Clinicopathologic correlations
Dr Abu Suraih Sakhri
MBBS, MD (Pathology)
www.abusuraihsakhri.com
Slide 2 · Learning objectives
Distinguish invasive carcinoma of no special type from special histologic subtypes.
Explain the three morphologic variables used in Nottingham histologic grading.
Recognize characteristic invasive architectures and their diagnostic mimics.
Relate selected subtypes to receptor groups, dissemination, and clinical presentation.
Separate inflammatory carcinoma as a presentation from histologic classification.
Slide 3 · The organizing principle: Architecture before label
Identify invasion
Recognize malignant epithelial cells infiltrating breast stroma.
Classify pattern
No special type, or a definable special morphology.
Characterize biology
Assess grade and relevant receptor phenotype.
Slide 4 · Most invasive breast malignancies are adenocarcinomas
Approximately 20 morphologically defined subtypes of invasive carcinoma.
Histologic type reflects tumor architecture, growth pattern, and cellular morphology.
Special types have distinctive morphologic phenotypes; Not every pattern is a separate type.
Type, grade, and receptor expression describe different dimensions of a carcinoma.
Slide 5 · No special type dominates the classification
Invasive breast carcinoma of no special type (NST) accounts for approximately 75% of invasive cases.
A heterogeneous category • Not one uniform microscopic architecture
Slide 6 · A special type must have distinctive morphology
Special types are separated from NST by characteristic tumor architecture or cytomorphology.
Some have recognizable genomic or receptor associations.
A specific pattern should not be equated automatically with a single molecular profile.
The source emphasizes selected informative subtypes rather than all named rare entities.
Slide 7 · NST: An irregular infiltrative architecture
Tumor cells infiltrate fibrofatty tissue in haphazard glands, nests, cords, or single cells.
The extent of associated stromal reaction is highly variable.
Irregular invasion can produce an ill-defined gross and radiologic margin.
Architectural variability helps explain the breadth of NST appearances.
Schematic architecture — not a tissue specimen
Slide 8 · Desmoplasia drives the classic hard mass
An exuberant fibrous stromal reaction commonly surrounds infiltrating NST glands or nests.
Stromal fibrosis contributes to firmness and irregular radiodense margins.
Cut sections may be chalky-white; Focal calcifications can produce a grating sensation.
This classical appearance is common, not universal.
Schematic architecture — not a tissue specimen
Slide 9 · NST can be deceptively well circumscribed
If tumor grows as sheets with little stromal reaction, the mass may appear circumscribed.
Circumscription does not demonstrate benignity or exclude invasive carcinoma.
Architectural assessment must consider the lesional periphery and surrounding tissue.
The source contrasts this pattern with strongly desmoplastic NST.
Slide 10 · NST may be almost invisible macroscopically
Scattered neoplastic glands or single cells can infiltrate otherwise unremarkable fat.
Weak desmoplastic response may make a primary tumor hard to palpate or image.
This mechanism helps explain some clinically occult invasive carcinomas.
An inconspicuous mass does not imply an in situ process.
Schematic architecture — not a tissue specimen
Slide 11 · Medullary pattern belongs within NST
Some high-grade NSTs form relatively cohesive sheets with prominent tumor-infiltrating lymphocytes.
These were previously designated “medullary carcinoma.”
The separate entity proved insufficiently reproducible diagnostically.
Robbins calls this NST with medullary pattern.
Schematic architecture — not a tissue specimen
Slide 12 · Tumor-infiltrating lymphocytes: Contextual feature
Prominent lymphocytes may accompany high-grade tumors showing a medullary pattern.
The inflammatory infiltrate is a tumor-associated microscopic observation.
It does not, by itself, establish a special histologic type.
Do not confuse this finding with the clinical entity inflammatory breast carcinoma.
Slide 13 · Nottingham grade measures differentiation
Tubule formation
How much of the tumor develops recognizable glandular lumina?
Nuclear pleomorphism
How variable and atypical are tumor nuclei?
Mitotic activity
How actively are cells dividing on histologic assessment?
Slide 14 · Grading and typing answer different questions
Descriptor
What it measures
Examples
Histologic type
Predominant architectural / cellular pattern
NST, lobular, tubular
Histologic grade
Differentiation and proliferation
Nottingham grades 1–3
Receptor phenotype
ER, PR, HER2 expression
Luminal-associated, HER2-positive, TNBC
Slide 15 · Tubule formation indicates glandular differentiation
Well-formed lumina reflect retention of glandular epithelial architecture.
Grade 1 carcinomas frequently grow in tubules or cribriform formations.
Poorly differentiated tumors tend to form solid nests or sheets.
Tubule formation is one component of the composite Nottingham assessment.
Schematic architecture — not a tissue specimen
Slide 16 · Nuclear pleomorphism indicates cytologic atypia
Grade 1 cells show relatively small, uniform nuclei.
With loss of differentiation, nuclei become enlarged and irregular.
Grade 3 carcinomas typically show striking nuclear atypia.
Nuclear morphology is interpreted together with architecture and mitoses.
Slide 17 · Mitotic activity estimates proliferative behavior
Grade 1 tumors show a low proliferative rate and scarce mitoses.
Grade 2 tumors have more mitotic figures than well-differentiated examples.
High mitotic activity commonly accompanies grade 3 morphology.
Counts require a standardized laboratory method; No unsupported numeric thresholds are given here.
Slide 18 · Grade 1: Structured glands and uniform nuclei
Tubular or cribriform glandular architecture predominates.
Nuclei are small and relatively monomorphic.
Mitotic figures are uncommon examples.
This combination represents well-differentiated morphology.
Schematic architecture — not a tissue specimen
Slide 19 · Grade 2: Mixed glandular and solid growth
Tumor may show glandular structures beside solid cell clusters.
Single infiltrating cells can be present.
Nuclear atypia and mitoses are intermediate relative to grades 1 and 3.
This represents moderately differentiated morphology.
Schematic architecture — not a tissue specimen
Slide 20 · Grade 3: Ragged nests and sheets
Infiltrating irregular sheets or nests replace organized gland formation.
Nuclei are enlarged and pleomorphic.
Proliferation is high and tumor necrosis may be present.
This combination signifies poorly differentiated morphology.
Schematic architecture — not a tissue specimen
Slide 21 · Morphologic differences across grades
Feature
Grade 1
Grade 2
Grade 3
Architecture
Tubular / cribriform
Mixed glands and solid clusters
Ragged nests / solid sheets
Nuclei
Small, uniform
More atypical
Large, irregular
Mitoses
Few
Intermediate
Many
Necrosis
Not characteristic
Variable
May be prominent
Slide 22 · Histologic grade is relevant across invasive types
All invasive carcinomas are graded using the Nottingham system.
The composite score incorporates tubule formation, pleomorphism, and mitotic rate.
Grade is not synonymous with invasive tumor size or anatomical stage.
Specific histologic types may differ substantially in their usual differentiation.
Slide 23 · Special histologic types form biologic clusters
Usually luminal
Lobular, mucinous, tubular, cribriform, papillary.
Often HER2-positive
Apocrine and invasive micropapillary.
Often triple-negative
Metaplastic and certain salivary gland–like types.
Slide 24 · “Usually” is not “always” for receptor groups
The subtype-to-receptor associations are probabilistic.
Histomorphology does not replace ER, PR, or HER2 testing.
Exceptions must remain possible even when a pattern is classical.
Receptor and histologic classifications supply complementary information.
Slide 25 · Invasive lobular carcinoma is the main special type
Invasive lobular carcinoma is second most common and accounts for up to 15% of invasive cases.
Defining feature: Loss of cellular cohesion • Often luminal ER-positive/HER2-negative
Slide 26 · Lobular carcinoma: A single-file invasion pattern
Dyscohesive neoplastic cells infiltrate as linear cords or individual cells.
The single-file architecture is a diagnostic morphologic hallmark.
Minimal mass-forming stromal reaction may conceal disease on imaging.
Assessment requires inspection of tumor distribution in the stroma.
Schematic architecture — not a tissue specimen
Slide 27 · Signet-ring change in lobular carcinoma
Intracytoplasmic mucin can displace the nucleus to the cellular periphery.
Signet-ring cells may be found amid dyscohesive tumor cells.
Distinguish intracellular mucin from large extracellular mucin lakes.
A signet-ring phenotype alone is not equivalent to mucinous carcinoma.
Schematic architecture — not a tissue specimen
Slide 28 · Lobular carcinoma often causes little desmoplasia
Rather than a conspicuous firm nodule, the lesion may diffusely infiltrate breast tissue.
Minimal stromal response contributes to subtle imaging findings.
Detection difficulties derive partly from how cells occupy the existing tissue.
Clinical and radiologic findings must be integrated with histology.
Slide 29 · E-cadherin links genotype to cell cohesion
CDH1 / E-cadherin
E-cadherin participates in epithelial cell-cell adhesion.
Loss of expression
Most invasive lobular carcinomas lose E-cadherin expression.
Dyscohesive growth
Cells separate and infiltrate as single files or small groups.
Slide 30 · The CDH1 germline association
Heterozygous germline CDH1 mutations in affected families.
Such carriers have increased risk for lobular breast carcinoma.
The same association encompasses gastric signet-ring carcinoma.
This is a susceptibility association, not evidence that every lobular carcinoma is hereditary.
Slide 31 · Lobular carcinoma has distinctive metastatic sites
Peritoneum and retroperitoneum are recognized sites.
Gastrointestinal tract, ovaries, and uterus can be involved.
Leptomeningeal spread may produce carcinomatous meningitis.
The unusual distribution broadens the differential diagnosis of secondary lesions.
Slide 32 · Lobular carcinoma versus NST
Feature
Invasive lobular
Invasive NST
Invasion
Dyscohesive, single-file cords
Variable glands, nests, sheets
Stromal reaction
Often scant
Often desmoplastic
E-cadherin
Usually lost
Not defined by loss
Detection
May be subtle / diffuse
Often irregular mass
Distinctive spread
Peritoneal and GI sites
No subtype-specific pattern stated here
Slide 33 · Mucinous carcinoma: Gelatinous gross appearance
The mass may be soft, rubbery, and gelatinous.
Gross borders can be pushing or relatively circumscribed.
Extracellular mucin accounts for its characteristic consistency.
Mucinous carcinoma belongs among the subtypes usually in the luminal group.
Schematic architecture — not a tissue specimen
Slide 34 · Mucinous carcinoma: Tumor islands in mucin
Neoplastic epithelial clusters float in abundant extracellular mucin lakes.
Cell clusters vary in size and arrangement.
The extracellular location of mucin is diagnostically essential.
This architecture explains the gelatinous cut-surface appearance.
Schematic architecture — not a tissue specimen
Slide 35 · Extracellular versus intracellular mucin
Feature
Mucinous carcinoma
Lobular carcinoma with signet-ring cells
Mucin location
Extensive extracellular mucin pools
Inside individual tumor cells
Tumor architecture
Clusters floating in mucin
Dyscohesive single files
Diagnostic emphasis
Mucin lakes and cell groups
Discohesion and epithelial phenotype
Slide 36 · Tubular carcinoma: Infiltrating well-formed glands
Invasive architecture consists of well-formed tubular structures.
The cells show a striking degree of glandular differentiation.
Tubular carcinoma is usually within the luminal receptor group.
Architecture can appear bland despite genuine stromal invasion.
Schematic architecture — not a tissue specimen
Slide 37 · Tubular carcinoma may mimic a benign lesion
Small, well-organized glands may be mistaken for a sclerosing benign process.
The central diagnostic question is the invasive arrangement of atypical tubules.
Apparent blandness does not eliminate the need to establish invasion.
This sclerosing-lesion diagnostic pitfall.
Slide 38 · Cribriform carcinoma: Perforated tumor nests
Invasive tumor nests contain multiple rounded punched-out spaces.
This creates a sieve-like or cribriform architecture.
Cribriform carcinoma usually belongs to the luminal group.
The key recognition feature is invasive cribriform growth.
Schematic architecture — not a tissue specimen
Slide 39 · Tubular versus cribriform architecture
Feature
Tubular carcinoma
Cribriform carcinoma
Principal structure
Separate small glandular tubules
Invasive nests with multiple lumina
Visual impression
Discrete open-lumen glands
Sieve-like nests
Shared association
Often ER-positive/HER2-negative
Often ER-positive/HER2-negative
Teaching pitfall
Can resemble sclerosing lesions
Do not identify type from a single lumen
Slide 40 · Papillary carcinoma contains true fibrovascular cores
The papillae are real fronds lined by neoplastic epithelial cells.
Each true papilla has a fibrovascular central axis.
Papillary carcinoma is included among usually luminal special types.
The presence of true cores distinguishes it from micropapillary pattern.
Schematic architecture — not a tissue specimen
Slide 41 · Papillary is an architectural, not receptor-only diagnosis
Observe cellular lining and supporting fibrovascular fronds.
Papillary histology must be assessed in the context of invasion.
An ER-positive result cannot independently identify papillary carcinoma.
Micropapillary carcinoma uses the name “papillary” despite lacking these cores.
Slide 42 · Luminal-associated special types: Comparison
Subtype
Signature morphology
Selected clinical/biologic note
Lobular
Single-file, dyscohesive cells
E-cadherin loss; unusual metastases
Mucinous
Clusters in mucin lakes
Soft gelatinous gross lesion
Tubular
Well-formed small glands
Can mimic benign sclerosis
Cribriform
Perforated invasive nests
Sieve-like architectural growth
Papillary
True epithelial-lined fibrovascular cores
Distinguish from micropapillary
Slide 43 · Apocrine carcinoma: Eosinophilic cytoplasm
Tumor cells resemble glandular cells lining sweat glands.
Cytoplasm is abundant, eosinophilic, and may be granular.
Nuclei are enlarged with conspicuous nucleoli.
Apocrine carcinoma among types more likely to overexpress HER2.
Schematic architecture — not a tissue specimen
Slide 44 · Apocrine morphology is not a HER2 test
The apparent apocrine phenotype is cytologic: Large nuclei, nucleoli, abundant cytoplasm.
HER2 overexpression is an association rather than a defining histologic criterion.
Direct receptor assessment remains necessary.
The source does not assert uniform HER2 positivity in apocrine carcinoma.
Slide 45 · Invasive micropapillary carcinoma forms hollow balls
Aggregates of neoplastic cells form hollow ball-like structures.
They lie in intercellular fluid spaces, giving an illusion of papillary formations.
The apparent papillae lack genuine fibrovascular cores.
Robbins groups this type among carcinomas more likely to overexpress HER2.
Schematic architecture — not a tissue specimen
Slide 46 · Micropapillary is a morphologic misnomer
Feature
True papillary carcinoma
Invasive micropapillary carcinoma
Core
Fibrovascular core present
No true fibrovascular core
Growth
Epithelial-lined fronds
Hollow balls in fluid spaces
Receptor association
Usually luminal
More likely HER2-overexpressing
Classification lesson
True papillary architecture
Papillary-like illusion
Slide 47 · HER2-associated morphologies are not interchangeable
Apocrine and micropapillary carcinomas are architecturally dissimilar.
Apocrine refers mainly to eosinophilic granular cytoplasm and nucleoli.
Micropapillary refers to hollow cell clusters lacking true vascular cores.
Their shared HER2 association must not obscure these structural differences.
Slide 48 · Metaplastic carcinoma shows divergent differentiation
Carcinoma develops overt squamous or mesenchymal-like differentiation.
Mesenchymal-like elements may be spindle-shaped, cartilaginous, or osseous.
Many metaplastic tumors are triple-negative.
The category is biologically and prognostically heterogeneous.
Schematic architecture — not a tissue specimen
Slide 49 · Squamous differentiation in metaplastic carcinoma
Neoplastic epithelium acquires a squamous phenotype.
This is evidence of divergent tumor differentiation.
The epithelial lineage must be reconciled with the unusual histology.
Not all metaplastic carcinomas are predominantly squamous.
Schematic architecture — not a tissue specimen
Slide 50 · Spindle and mesenchymal morphology
Spindle-cell architecture can resemble a primary stromal lesion.
Other metaplastic forms may display chondroid or osseous differentiation.
The broad phenotype explains important morphologic differential diagnoses.
The subtype is not defined by a single uniform cell shape.
Schematic architecture — not a tissue specimen
Slide 51 · Metaplastic tumors may express myoepithelial-like profiles
Many metaplastic carcinomas with myoepithelial-like gene expression.
These tumors are frequently triple-negative by ER, PR, and HER2 criteria.
The molecular resemblance is a group-level observation.
Do not infer a specific marker positivity rate or diagnostic panel from this excerpt.
Slide 52 · Metaplastic carcinoma: Prognosis is not uniform
Metaplastic breast carcinoma is often associated with poor clinical outcome.
Robbins recognizes unusual indolent metaplastic subtypes.
Low-grade adenosquamous carcinoma is one example.
Fibromatosis-like metaplastic carcinoma is another exception.
Broad categorization must preserve these prognostic distinctions.
Slide 53 · Low-grade adenosquamous carcinoma
An uncommon, relatively indolent metaplastic subtype.
The name reflects the combination of glandular and squamous differentiation.
It should not be presumed to share the outcome of aggressive metaplastic forms.
Exact diagnostic criteria are not detailed in the supplied section.
Slide 54 · Fibromatosis-like metaplastic carcinoma
An uncommon, relatively indolent metaplastic subtype.
Its fibromatosis-like growth broadens the differential of spindle-cell breast lesions.
Its clinical behavior differs from the generally aggressive metaplastic group.
Detailed immunohistochemical criteria are beyond the provided Robbins excerpt.
Slide 55 · Triple-negative carcinomas are histologically diverse
TNBC means absence of ER, PR, and HER2 expression, not one morphology.
Metaplastic carcinomas are commonly triple-negative and often aggressive.
Some triple-negative salivary gland–like carcinomas have a comparatively favorable course.
Receptor status alone cannot determine prognosis without tumor type and extent.
Slide 56 · Salivary gland–like breast carcinomas
Adenoid cystic
Rare breast counterpart of salivary gland morphology.
Mucoepidermoid
Rare tumor with the salivary-type designation.
Secretory
Rare subtype with distinctive histologic morphology.
Slide 57 · Salivary gland–like types: A prognostic exception
Robbins groups adenoid cystic, mucoepidermoid, and secretory breast carcinomas.
They closely resemble corresponding salivary gland tumors.
These rare forms are usually triple-negative yet are relatively favorable compared with usual aggressive TNBC patterns.
This demonstrates why histologic type can qualify receptor-based expectations.
Slide 58 · Adenoid cystic carcinoma
An uncommon salivary gland–like subtype of invasive breast carcinoma.
It among rare triple-negative tumors with relatively favorable prognosis.
Its designation reflects similarity to its salivary gland counterpart.
The supplied section does not provide detailed architecture or molecular criteria.
Slide 59 · Mucoepidermoid carcinoma
An uncommon breast carcinoma analogous to the salivary gland entity.
It belongs to a small favorable-outcome group of triple-negative special types.
The given textbook excerpt lists the type without detailed morphology.
Avoid adding unverified diagnostic thresholds or translocation claims.
Slide 60 · Secretory carcinoma: A distinct special type
Secretory carcinoma is a rare salivary gland–like breast carcinoma.
It among special types and groups it with relatively favorable TNBC subtypes.
The label denotes a distinct histologic type, not nonspecific glandular secretion.
Exact molecular alterations are not provided in the supplied source excerpt.
Slide 61 · Subtype, receptor phenotype, and outcome
Group
Selected types
Robbins emphasis
Usually luminal
Lobular, mucinous, tubular, cribriform, papillary
Distinct architectures; usually ER+/HER2−
More likely HER2+
Apocrine, micropapillary
Distinct cytology vs structure
Often TNBC, aggressive
Many metaplastic forms
Squamous / mesenchymal differentiation
Rare TNBC, favorable
Adenoid cystic, mucoepidermoid, secretory
Salivary gland–like counterparts
Slide 62 · Inflammatory breast carcinoma is not a histologic type
“Inflammatory” breast carcinoma describes a clinical presentation caused by dermal lymphovascular tumor emboli.
Clinical syndrome, not a distinctive epithelial architecture • The term does not imply primary infection
Slide 63 · Dermal lymphovascular obstruction causes edema
Extensive carcinoma cell plugs occupy dermal lymphovascular spaces.
Lymphatic outflow obstruction produces diffuse swelling and skin thickening.
Clinical erythema accompanies the edematous presentation.
The defining mechanism is tumor embolization, not inflammatory-cell infiltrates.
Schematic architecture — not a tissue specimen
Slide 64 · Peau d’orange is a mechanical consequence
Edematous skin remains tethered to deep breast structures by Cooper ligaments.
Localized tethering against diffuse swelling produces an orange-peel texture.
The skin changes reflect dermal lymphatic blockage and fixation.
This finding can occur without a palpable discrete mass.
Carcinoma embolus
Schematic architecture — not a tissue specimen
Slide 65 · Inflammatory carcinoma: Why clinical confusion occurs
Erythema and swelling may resemble an infectious process.
The designation is a misnomer because inflammatory infiltrates are typically not the explanation.
Delay can occur if the appearance is attributed solely to infection.
Underlying carcinoma is commonly high grade and diffusely infiltrative.
Slide 66 · Most invasive cancers present as a palpable or screened mass
Primary cancers are identified by palpation or imaging-based screening.
Screen-detected cancers are often smaller luminal tumors confined to the breast.
Clinically apparent masses are more common with aggressive HER2-positive and triple-negative disease.
The detection pattern is an association, not a substitute for receptor testing.
Slide 67 · Advanced local growth alters the breast examination
Pectoralis invasion can produce fixation to the chest wall.
Dermal involvement can result in retraction or dimpling.
Central tumors may retract the nipple.
These clinical findings reflect anatomic extent rather than a specific histologic subtype.
Slide 68 · Occult primary carcinoma may first appear as metastasis
An axillary node or distant metastasis may occasionally precede identification of the breast primary.
The primary can be small, obscured by dense tissue, or minimally desmoplastic.
Ultrasound or MRI may reveal lesions missed by examination or mammography.
Insidious invasive patterns should remain in the differential.
Slide 69 · Illustrative case: Subtle invasive lobular carcinoma
Illustrative teaching vignette
Breast imaging shows only ill-defined subtle distortion. Histology reveals individual tumor cells aligned in linear cords with limited stromal response.
Interpretation
Pattern favors invasive lobular carcinoma rather than a desmoplastic NST mass.
E-cadherin loss is an expected biologic association, not a replacement for morphology.
A weakly palpable lesion is consistent with insidious infiltration.
Slide 70 · Illustrative case: Grading a high-grade NST
Illustrative teaching vignette
An invasive lesion grows as irregular sheets. Tumor cells have enlarged pleomorphic nuclei, conspicuous mitotic activity, and a focus of necrosis.
Interpretation
Morphology is compatible with poorly differentiated (grade 3) carcinoma.
Grading rests on gland formation, nuclear atypia, and mitotic rate together.
The histologic grade alone does not establish HER2 or triple-negative status.
Slide 71 · Illustrative case: Papillary or micropapillary?
Illustrative teaching vignette
An invasive tumor forms round cellular aggregates apparently floating in tissue spaces. No central fibrovascular core is seen in the aggregates.
Interpretation
The absence of true cores favors invasive micropapillary architecture.
True papillary carcinoma instead contains epithelial-lined fibrovascular fronds.
Assess HER2 directly; A receptor association is not proof of type.
Slide 72 · Illustrative case: A triple-negative spindle lesion
Illustrative teaching vignette
An invasive breast malignancy shows a substantial spindle-cell component. ER, PR, and HER2 are negative.
Interpretation
Metaplastic carcinoma belongs in the differential because mesenchymal-like growth is recognized.
Triple-negative status supports a group association but does not independently establish type.
Clinical behavior differs among metaplastic subtypes.
Slide 73 · Pattern-based differential: Five recognition pivots
Look for
Consider
Exclude confusion with
Single-file discohesive cells
Invasive lobular
NST with scattered glands
Large extracellular mucin lakes
Mucinous
Signet-ring intracellular mucin
Infiltrating well-formed small glands
Tubular
Benign sclerosis
True fibrovascular cores
Papillary
Micropapillary
Hollow clusters without true cores
Micropapillary
Papillary
Spindle / squamous elements
Metaplastic
Purely stromal lesion
Slide 74 · Histologic pattern is a map, not the whole diagnosis
Histologic type captures reproducible growth pattern and tumor cytology.
Nottingham grade captures degree of differentiation and cell division.
ER, PR, and HER2 provide biologic and therapeutic context.
Clinical extent and metastatic spread remain separate dimensions.
Subtype assessment should preserve uncertainty when architecture is incomplete.
Slide 75 · Five distinctions that prevent classification errors
NST with medullary pattern is not a separate medullary histologic type.
Papillary carcinoma has real fibrovascular cores; Micropapillary carcinoma does not.
Lobular signet-ring change is not equivalent to extracellular mucinous growth.
Triple-negative receptor status does not imply a single prognosis.
Inflammatory carcinoma is a clinical syndrome, not a special microscopic carcinoma subtype.
Slide 76 · Primary reference and source limits
Robbins, Cotran & Kumar: Pathologic Basis of Disease, 11th edition (2026), Chapter 23, The Breast.
Core source: “Types of Invasive Breast Carcinoma,” printed pp. 961–964.
Adjacent source context: “Clinical Presentation” (p. 964) and prognostic factors (p. 964).
Figures 23.20–23.22 were described in source text but not reproduced; native figures here are explanatory schematics.
Original chapter PDF was not available for direct page/figure verification.